Zenas BioPharma, Inc. (ZBIO)

NASDAQ: ZBIO · Real-Time Price · USD

21.95

+1.72 (8.50%)

At close: Sep 15, 2025, 4:00 PM EDT

21.95

0.00 (0.00%)

After-hours: Sep 15, 2025, 4:28 PM EDT

Revenue by Product

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Immune-based Therapies	5.00M	Log In
Immune-based Therapies Growth	-90.00%	Log In

Revenue by Geography

Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
United States	5.00M	Log In
United States Growth	-90.00%	Log In